Ray Dalio's OVV Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 1.24 M shares of Ovintiv Inc. (OVV) worth $48.58 M, representing 0.18% of the portfolio. First purchased in 2020-Q1, this long-term strategic position has been held for 21 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in OVV, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 371,343 shares. Largest reduction occurred in Q4 2023, reducing 141,792 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Ovintiv (OVV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ovintiv (OVV) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +126,850 | Add 11.40% | 1.24 M | $39.19 |
| Q3 2025 | +371,343 | Add 50.09% | 1.11 M | $40.38 |
| Q2 2025 | +253,309 | Add 51.90% | 741,422 | $38.05 |
| Q1 2025 | +196,472 | Add 67.37% | 488,113 | $42.80 |
| Q4 2024 | +55,125 | Add 23.31% | 291,641 | $40.50 |
| Q3 2024 | -40,379 | Reduce 14.58% | 236,516 | $38.31 |
| Q2 2024 | -50,603 | Reduce 15.45% | 276,895 | $46.87 |
| Q1 2024 | -12,654 | Reduce 3.72% | 327,498 | $51.90 |
| Q4 2023 | -141,792 | Reduce 29.42% | 340,152 | $43.92 |
| Q3 2023 | +325,498 | Add 208.06% | 481,944 | $47.57 |
| Q2 2023 | +50 | Add 0.03% | 156,446 | $38.07 |
| Q1 2023 | +94,100 | Add 151.05% | 156,396 | $36.08 |
| Q4 2022 | +62,296 | New Buy | 62,296 | $50.71 |
| Q3 2022 | -48,232 | Sold Out | 0 | $0.00 |
| Q2 2022 | -17,359 | Reduce 26.47% | 48,232 | $44.14 |
| Q1 2022 | -1,742 | Reduce 2.59% | 65,591 | $54.14 |
| Q4 2021 | +67,333 | New Buy | 67,333 | $33.70 |
| Q4 2020 | -65,605 | Sold Out | 0 | $0.00 |
| Q2 2020 | -13,303 | Reduce 16.86% | 65,605 | $9.48 |
| Q1 2020 | +78,908 | New Buy | 78,908 | $2.71 |
Ray Dalio's Ovintiv Investment FAQs
Ray Dalio first purchased Ovintiv Inc. (OVV) in Q1 2020, acquiring 78,908 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Ovintiv Inc. (OVV) for 21 quarters since Q1 2020.
Ray Dalio's largest addition to Ovintiv Inc. (OVV) was in Q3 2025, adding 1,112,765 shares worth $44.93 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 1,239,615 shares of Ovintiv Inc. (OVV), valued at approximately $48.58 M.
As of the Q4 2025 filing, Ovintiv Inc. (OVV) represents approximately 0.18% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Ovintiv Inc. (OVV) was 1,239,615 shares, as reported at the end of Q4 2025.